[ad_1]
MAINZ, Germany (December 22): The question of whether Covid-19 vaccines work against the new mutant coronavirus has been raised in recent days around the world after the emergence of a new strain of coronavirus in the UK.
The founder of the German biotechnology company BioNTech, Ugur Sahin, answered this question by speaking to Anadolu Video News Agency (AAVN) during a video call via zoom last night.
Sahin said they believe his company’s Covid-19 vaccine, developed jointly with Pfizer, will be effective against the mutant virus.
“We are not concerned that our vaccine will not work,” Sahin said.
He said: “This is not the first mutated virus. There have been several mutations before. We have checked all those past mutations and we do not consider them a problem. ”
Sahin said there is not much information about the new variant of the coronavirus, which is said to be more infectious, as no scientific files on the subject have yet been released.
He emphasized that one percent of the genetic code of the virus has changed but 99 percent remains the same.
“About 99% of the vaccine is sufficient for effectiveness. Because our vaccine is effective in a wide variety of positions, “he added.
BioNTech’s CEO said his company will investigate the UK mutation in the coming days.
The coronavirus strain has caused Covid-19 cases to spike in the UK, forcing the British government to impose the toughest measures in some parts of the country.
The country entered the Level 4 lockdown, much like a full lockdown, for millions of people after saying that the new variant causes a large increase in cases.
The nations of the world closed their borders to the UK after the country’s prime minister announced the news of a more infectious mutant coronavirus.
[ad_2]
